Navigation Links
Study: Delaying evolution of drug resistance in malaria parasite possible
Date:9/4/2008

GAINESVILLE, Fla. --- There's no magic bullet for wiping out malaria, but a new study offers strong support for a method that effectively delays the evolution of drug resistance in malaria parasites, a University of Florida researcher says.

David Smith, associate director of disease ecology at UF's Emerging Pathogens Institute, said the study will guide scientists and policy makers in extending the longevity of current artemisinin-based malaria drugs combined with partner drugs. Smith is a co-author of a report on the study, scheduled to publish online this week in the Proceedings of the National Academy of Sciences and in print on Sept. 16.

Smith collaborated with lead author Maciej Boni of Resources for the Future and Princeton University, and Ramanan Laxminarayan, also with RFF, to create mathematical models assessing the strategic effectiveness and clinical outcomes of using one, two and three first-line drug therapies to treat malaria within a population over a 20-year period. Their results show that using two or three drugs simultaneously reduced the total clinical cases and number of failed treatments , and slowed the rate at which drug-resistant genes spread within the parasites that cause malaria: Plasmodium falciparum, P. vivax, P. malariae and P. ovale.

"The models indicate that we can slow the evolution of resistance to current artemisinin-based therapies if nations use them in combination with two or more partner drugs," Smith said. "Currently, most nations don't do this. They use one therapy at a time, wait for it to fail, and then switch to a different therapy."

Artemisinin-combined therapies, or ACTs, are currently not widely implemented due to operational challenges and expense, Smith said. But he said the study offers compelling evidence for global leaders to collaborate and overcome these issues.

"This is not to say that implementing multiple first-line therapies solves all of our malar
'/>"/>

Contact: DeLene Beeland
tdb@epi.ufl.edu
352-870-6856
University of Florida
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. U. of Chicago study: More than 10 percent of older Americans suffer mistreatment
2. UNC study: chilling hardship rates among families raising disabled children
3. UNC study: Two-thirds of severe sports injuries to female students due to cheerleading
4. UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine therapies
5. Study: verbal aggression may affect childrens behavior
6. UNC study: Common vaginal infection may increase risk of HIV infection
7. Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomes
8. UNC study: Out-of-pocket health care costs for disabled children vary widely by state
9. Study: Global Business Performance Significantly Improved Through Project Management
10. Geisinger study: PTSD causes early death from heart disease
11. Study: 9/11 Dogs Suffered Few Health Effects

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e/--TwomoreH1N1vaccineclinicshavebeenscheduledforT...thDepartmentannouncedtoday.Theyarebeingofferedatno...rlingHeights. ,, TheDec.3clinicwillbeheldfromno...merosol-freeversionoftheinjectablevaccinewillbeava...andnasalsprayimmunizationwillbeoffered.Pregnantwom...
(Date:11/25/2009)...ntial to normal human development - the Wnt/Wingle...R) pathways - interact in ways that can promote tu... The University of Texas M. D. Anderson Cancer Cen... . , This newly characterized interaction involv...ith invasive cancer - activation of EGFR, elevated...
(Date:11/25/2009)... , An innovative treatment for HIV patients ...rchers has passed its first clinical trial with fl... customized for each individual patient, and was d...tute of the MUHC in collaboration with Dr. R. Skal...e made for the individual patient an "haute coutu...
(Date:11/25/2009)... to enjoy festive feasting , , WEDNESDAY...-week holiday smorgasbord from Thanksgiving to New... pounds you,ll have to sweat off come Jan. 1, help...erts, to enjoy holiday eating and make it to 201...l about devising a strategy and thinking about hol...
(Date:11/25/2009)...wswire/--/EINNews/EINNews,anonlineleaderinindustry...esthealth-relatedpublicationforindustryprofessiona...om ). ,, H1N1NewsTodaygathersthelatestinformati...andresearchcenterstheworldover,searchingbeyondthef...ithreportsfromeverystateandeverycountry. ,, Dig...
Breaking Medicine News(10 mins):Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News 2
...ations are rising and tough to get rid of, experts...) -- Although bed bugs might prevent you from slee...n,t appear to transmit illness, a new report finds...the Journal of the American Medical Association ,...
...sful Collaboration with the U.S. Army , , - U.S. ...ell,s first marketed product, a new vaccine agains...litary personnel , , - Success of Intercell,s new...act for IXIARO with the U.S. military, to be concl...
...e,s periapproval services experts to discuss REMS ...ETON, N.J., March 31 Covance Inc. (NYSE: CVD ...ment and risk evaluation and mitigation strategies...ce president of medical affairs for periapproval s...
...ON , March 31 The following is a statement from...merica,s Health (TFAH): , , Today,s recall of pis...ur food safety system is. Our current food safety ...urced, and understaffed. It is encouraging that th...
...y Tracking Tools Bring Women Together To Share and... March 31 23andMe , Inc., an industry leader i...aunched a free pregnancy community and research ...all women. , , Moms of all ages are welcome to pa...
... ConsumerLab.com Uncovers Defects ...d Finds Most Children,s Multivitamins Exceed Toler...s, New York (PRWEB) March 31, 2009 -- Over 30% of ...inated with lead. In addition, several products (i...
Other Medicine News:Health News:Bed Bugs Bring No Disease Danger 2Health News:Bed Bugs Bring No Disease Danger 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 2Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 4Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 5Health News:Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum 2Health News:Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum 3Health News:Trust for America's Health on the Recall of Certain Pistachios and the U.S. Food Safety System 2Health News:23andMe Launches Free Online Community for Moms and Moms-to-Be 2Health News:23andMe Launches Free Online Community for Moms and Moms-to-Be 3Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 2Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 3Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 4Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 5
(Date:11/24/2009)...irstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS...perJaffrayHealthcareConferenceonTuesday,December1,...gheldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pr...eanoverviewofAnadysanditsclinicaldevelopmentprogra...willbesimultaneouslywebcastandcanbeaccessedontheIn...
(Date:11/24/2009)...wire/--ZargisMedicalCorp.,asubsidiaryofSpeedusCorp...search(NYSE: SI ),todayannouncedthatitsZargisCardi...fCBS, TheEarlyShow duringasegmentinwhichMarkJannot...inningproductsfromthepublication,s2009"BestofWhat,...elevisionmorningnewstalkshowbroadcastbyCBSfromNewY...
(Date:11/24/2009)...-USNewswire/--America,spharmaceuticalresearchandbi...estotreatorpreventHIV/AIDSandrelatedconditions,acc...ResearchandManufacturersofAmerica(PhRMA).December1...renesscampaignthatoriginatedatthe1988WorldSummitof..., "Wearegreatlyencouragedbythesecriticallyimport...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 1Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 1Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 4ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 1ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 2ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 3
...wswire/ -- Mersana, a,cancer therapeutics company,...es with its lead product candidate, XMT-1001, will...eting of the,American Association of Cancer Resear...s, CA. Full text of the abstracts can be,viewed on...f=,"http://www.aacr.org/">http://www.AACR.org . , ...
...e Oncology Compounds at the,American Association f...l., April 13, 2007 /PRNewswire-FirstCall/ -- For,d...hat target,cancer. Researchers now know that cance...y require new blood vessels to deliver oxygen,and ...,(proliferation), they travel throughout the body ...
Other Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 3Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 4
...nsfers depurinated DNA and RNA from agarose gels t...es ,Increases speed and efficiency of transfer by ...of an integrated system allowing electrophoresis, ... hours, versus 29 hours required for conventional ...
...nsfers depurinated DNA and RNA from agarose gels t...es ,Increases speed and efficiency of transfer by ...of an integrated system allowing electrophoresis, ... hours, versus 29 hours required for conventional ...
PosiBlot 30-30 Pads
Liquid Trap
Medicine Products: